Omicron-specific Sinopharm Covid-19 vaccine candidates cleared for clinical trial

  • 📰 STForeignDesk
  • ⏱ Reading Time:
  • 13 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 9%
  • Publisher: 71%

Singapore Headlines News

Singapore Latest News,Singapore Headlines

BEIJING - Two Covid-19 vaccine candidates developed by units of China National Biotec Group to target the Omicron variant were approved for clinical trials as boosters in Hong Kong, the Sinopharm su

bsidiary said on Saturday .

The two candidates, both containing inactivated or"killed" Omicron virus and similar to the two Sinopharm vaccines in use in China, will be tested in adults who have already received two or three vaccine doses, CNBG said in a statement.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 4. in SG

Singapore Latest News, Singapore Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.